FridayOL

Eli Lilly's Bold Plan: How They Aim to Conquer the $95 Billion Obesity Treatment Market

INSIDER

Eli Lilly is making waves in the pharmaceutical industry, rapidly gaining ground on Novo Nordisk in the development of innovative incretin-based drugs. But their ambitions extend far beyond simply catching up – Eli Lilly is strategically positioning ...undefined